FibroBiologics, Inc. (FBLG)
NASDAQ: FBLG · Real-Time Price · USD
0.2601
+0.0089 (3.54%)
Feb 20, 2026, 2:36 PM EST - Market open
FibroBiologics Market Cap
FibroBiologics has a market cap or net worth of $17.3 million as of February 20, 2026. Its market cap has decreased by -68.19% in one year.
Market Cap
17.30M
Enterprise Value
18.96M
1-Year Change
-68.19%
Ranking
Category
Stock Price
$0.26
Market Cap Chart
Since January 31, 2024, FibroBiologics's market cap has decreased from $945.52M to $17.30M, a decrease of -98.17%. That is a compound annual growth rate of -85.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 19, 2026 | 16.71M | 11.69% |
| Dec 31, 2025 | 14.96M | -78.68% |
| Dec 31, 2024 | 70.17M | -92.58% |
| Jan 31, 2024 | 945.52M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Serina Therapeutics | 17.80M |
| CASI Pharmaceuticals | 16.93M |
| IN8bio | 16.80M |
| Citius Pharmaceuticals | 16.59M |
| Lexaria Bioscience | 16.17M |
| Pasithea Therapeutics | 16.00M |
| Klotho Neurosciences | 15.88M |
| Phio Pharmaceuticals | 15.82M |